Development of the optimal scheme for the synthesis of the dipeptide TSPO ligand, N-phenylpropionyl-L-tryptophanyl-L-leucine amide (GD-102), a potential anxiolytic drug
Previously at the Zakusov Research Institute of Pharmacology the first dipeptide ligand TSPO, the compound N-phenylpropionyl-L-tryptophanyl-L-leucine amide (laboratory code GD-102), was designed and synthesized. The anxiolytic activity was detected for this compound at the doses 0.01–1.0 mg/kg intra...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Article |
| Langue: | russe |
| Publié: |
LLC “Publisher OKI”
2024-01-01
|
| Collection: | Фармакокинетика и Фармакодинамика |
| Sujets: | |
| Accès en ligne: | https://www.pharmacokinetica.ru/jour/article/view/396 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|